Table 1 Descriptive characteristics, anthropometric and hemodynamic data for 22 men and women assigned to Glavonoidâ„¢ or placebo for eight weeks.
Variable | Glavonoidâ„¢ Pre (n = 11) | Glavonoidâ„¢ Post (n = 11) | Placebo Pre (n = 11) | Placebo Post (n = 11) |
|---|---|---|---|---|
Compliance to Treatment (%) | NA | 94.8 ± 1.4 | NA | 97.0 ± 1.2 |
Age (years) | 28.4 ± 2.8 | 28.4 ± 2.8 | 25.7 ± 1.8 | 25.7 ± 1.8 |
Height (cm) | 173.9 ± 3.5 | 173.9 ± 3.5 | 175.4 ± 2.8 | 175.4 ± 2.8 |
Body Weight (kg) | 88.7 ± 4.0 | 88.6 ± 3.7 | 92.3 ± 2.9 | 92.0 ± 3.0 |
BMI (kg·m-2) | 29.4 ± 1.3 | 29.4 ± 1.2 | 30.2 ± 1.2 | 30.1 ± 1.3 |
Waist (cm) | 88.5 ± 3.2 | 88.9 ± 3.0 | 90.7 ± 2.0 | 90.9 ± 2.1 |
Hip (cm) | 113.8 ± 2.3 | 114.2 ± 2.3 | 114.6 ± 2.3 | 113.7 ± 2.2 |
Waist:Hip | 0.78 ± 0.02 | 0.78 ± 0.02 | 0.79 ± 0.02 | 0.80 ± 0.02 |
DEXA Total Body Fat (%) | 33.0 ± 2.9 | 32.7 ± 3.2 | 32.1 ± 2.1 | 32.2 ± 2.1 |
DEXA Trunk Body Fat (%) | 34.1 ± 2.7 | 34.0 ± 3.2 | 32.8 ± 2.4 | 32.5 ± 2.2 |
Total Fat Mass (kg) | 29.1 ± 2.8 | 28.8 ± 2.9 | 29.8 ± 2.4 | 29.7 ± 2.4 |
Total Fat Free Mass (kg) | 59.7 ± 3.9 | 59.8 ± 3.9 | 62.5 ± 2.5 | 62.2 ± 2.5 |
Skinfold Thickness (mm) | 228.7 ± 19.0 | 221.0 ± 16.6 | 231.6 ± 11.1 | 217.9 ± 13.2 |
Heart Rate (bpm) | 64.8 ± 3.1 | 63.9 ± 2.2 | 66.4 ± 1.8 | 68.1 ± 2.7 |
Systolic Blood Pressure (mmHg) | 114.7 ± 3.4 | 114.4 ± 2.8 | 108.9 ± 3.4 | 111.8 ± 2.4 |
Diastolic Blood Pressure (mmHg) | 75.1 ± 3.2 | 74.9 ± 3.0 | 70.3 ± 2.1 | 73.3 ± 2.5 |